These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


867 related items for PubMed ID: 8096421

  • 1. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A, Robertson JD, Willingham T.
    Brain Res; 1993 Feb 19; 603(2):186-200. PubMed ID: 8096421
    [Abstract] [Full Text] [Related]

  • 2. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents.
    Randich A, Thurston CL, Ludwig PS, Timmerman MR, Gebhart GF.
    Brain Res; 1991 Mar 15; 543(2):256-70. PubMed ID: 2059834
    [Abstract] [Full Text] [Related]

  • 3. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L, Rivière PJ, Pascaud X, Dassaud M, Junien JL.
    Eur J Pharmacol; 1994 May 12; 257(1-2):181-7. PubMed ID: 8082700
    [Abstract] [Full Text] [Related]

  • 4. Effects of intrathecal mu, delta, and kappa agonists on thermally evoked cardiovascular and nociceptive reflexes in halothane-anesthetized rats.
    Nagasaka H, Yaksh TL.
    Anesth Analg; 1995 Mar 12; 80(3):437-43. PubMed ID: 7864404
    [Abstract] [Full Text] [Related]

  • 5. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
    Yuan CS, Foss JF.
    Neuropharmacology; 1999 Mar 12; 38(3):425-32. PubMed ID: 10219980
    [Abstract] [Full Text] [Related]

  • 6. Intravenous morphine-induced activation of vagal afferents: peripheral, spinal, and CNS substrates mediating inhibition of spinal nociception and cardiovascular responses.
    Randich A, Thurston CL, Ludwig PS, Robertson JD, Rasmussen C.
    J Neurophysiol; 1992 Oct 12; 68(4):1027-45. PubMed ID: 1432065
    [Abstract] [Full Text] [Related]

  • 7. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 12; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 8. Effects of mu-, delta- and kappa-agonists on isolated right atria of the rat.
    Micol JA, Laorden ML.
    Neuropeptides; 1994 Jun 12; 26(6):365-70. PubMed ID: 7936123
    [Abstract] [Full Text] [Related]

  • 9. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug 12; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 10. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L, Rivière PJ, Pascaud X, Junien JL.
    Eur J Pharmacol; 1994 Dec 12; 271(1):65-71. PubMed ID: 7698213
    [Abstract] [Full Text] [Related]

  • 11. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
    Calcagnetti DJ, Holtzman SG.
    Pharmacol Biochem Behav; 1991 Jan 12; 38(1):185-90. PubMed ID: 2017444
    [Abstract] [Full Text] [Related]

  • 12. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.
    Danzebrink RM, Green SA, Gebhart GF.
    Pain; 1995 Oct 12; 63(1):39-47. PubMed ID: 8577489
    [Abstract] [Full Text] [Related]

  • 13. Interaction between halothane and mu, delta and kappa opioid agonists on the isolated right atria of the rat.
    Micol JA, Laorden ML.
    Br J Anaesth; 1992 Nov 12; 69(5):487-91. PubMed ID: 1334686
    [Abstract] [Full Text] [Related]

  • 14. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
    Collin E, Mauborgne A, Bourgoin S, Benoliel JJ, Hamon M, Cesselin F.
    Neuropeptides; 1994 Jul 12; 27(1):75-83. PubMed ID: 7969822
    [Abstract] [Full Text] [Related]

  • 15. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS.
    Eur J Pharmacol; 1996 Oct 24; 314(1-2):27-32. PubMed ID: 8957215
    [Abstract] [Full Text] [Related]

  • 16. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS, Williams CL, Burks TF, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1988 Apr 24; 245(1):238-43. PubMed ID: 2834537
    [Abstract] [Full Text] [Related]

  • 17. Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat.
    Guirimand F, Strimbu-Gozariu M, Willer JC, Le Bars D.
    J Pharmacol Exp Ther; 1994 Jun 24; 269(3):1007-20. PubMed ID: 7912273
    [Abstract] [Full Text] [Related]

  • 18. Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Bhargava HN, Cao YJ, Zhao GM.
    Brain Res; 1997 Mar 28; 752(1-2):234-8. PubMed ID: 9106462
    [Abstract] [Full Text] [Related]

  • 19. Opioid receptor-mediated control of acetylcholine release in human neocortex tissue.
    Feuerstein TJ, Gleichauf O, Peckys D, Landwehrmeyer GB, Scheremet R, Jackisch R.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov 28; 354(5):586-92. PubMed ID: 8938656
    [Abstract] [Full Text] [Related]

  • 20. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E, Frechilla D, Pohl M, Bourgoin S, Le Bars D, Hamon M, Cesselin F.
    Brain Res; 1993 Apr 23; 609(1-2):211-22. PubMed ID: 8389648
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.